Clinical Trial Update: Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of bovine intestinal alkaline phosphatase in patients with moderate to severe ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Bovine intestinal alkaline phosphatase (bovine intestinal alkaline phosphatase)

Snippet

Sponsor: AM-Pharma | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED